Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

BIOR

Biora Therapeutics Inc

Jul 26 • 04:00PM ET

0.6677

Dollar change +0.0127
Percentage change 1.94	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-7.12	Insider Own	1.11%	Shs Outstand	35.94M	Perf Week	1.17%
Market Cap	24.00M	Forward P/E	-	EPS next Y	-1.24	Insider Trans	0.00%	Shs Float	35.55M	Perf Month	4.74%
Income	-110.86M	PEG	-	EPS next Q	-0.45	Inst Own	52.94%	Short Float	3.73%	Perf Quarter	10.00%
Sales	0.54M	P/S	44.44	EPS this Y	80.06%	Inst Trans	4.87%	Short Ratio	5.22	Perf Half Y	-27.19%
Book/sh	-3.29	P/B	-	EPS next Y	24.39%	ROA	-291.43%	Short Interest	1.33M	Perf Year	-81.76%
Cash/sh	0.30	P/C	2.22	EPS next 5Y	-	ROE	-	52W Range	0.47 - 3.95	Perf YTD	-50.54%
Dividend Est.	-	P/FCF	-	EPS past 5Y	35.40%	ROI	-	52W High	-83.10%	Beta	1.22
Dividend TTM	-	Quick Ratio	0.28	Sales past 5Y	81.63%	Gross Margin	5.70%	52W Low	40.57%	ATR (14)	0.05
Dividend Ex-Date	-	Current Ratio	0.28	EPS Y/Y TTM	-52.63%	Oper. Margin	-12337.32%	RSI (14)	48.28	Volatility	6.93% 7.63%
Employees	58	Debt/Eq	-	Sales Y/Y TTM	172.00%	Profit Margin	-20379.23%	Recom	1.00	Target Price	10.30
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	91.01%	Payout	-	Rel Volume	0.24	Prev Close	0.65
Sales Surprise	-	EPS Surprise	68.89%	Sales Q/Q	27000.00%	Earnings	May 15 AMC	Avg Volume	254.25K	Price	0.67
SMA20	-0.43%	SMA50	-1.26%	SMA200	-37.12%	Trades		Volume	61,395	Change	1.94%

Jul-18-24 08:00AM	Biora Therapeutics Announces Supplemental Data from Phase 1 Clinical Trial of BT-600 as Presented at KOL Event (GlobeNewswire) -7.36%
Jul-08-24 08:00AM	Biora Therapeutics to Host Virtual KOL Event on NaviCap Targeted Oral Delivery Platform and Results from Phase 1 Clinical Trial of BT-600 on July 17, 2024 (GlobeNewswire)
Jul-01-24 08:00AM	Biora Therapeutics Announces Positive Clinical Trial Results for BT-600 (GlobeNewswire)
Jun-11-24 08:00AM	Biora Therapeutics Announces Presentation on the BioJet Systemic Oral Delivery Platform at the Next Gen Peptide Formulation & Delivery Summit 2024 (GlobeNewswire)
May-20-24 08:00AM	Biora Therapeutics Presents Clinical Data on Device Function of the NaviCap Platform at Digestive Disease Week 2024 (GlobeNewswire)
03:08AM	Loading…
May-16-24 03:08AM	Biora Therapeutics Inc (BIOR) Q1 2024 Earnings Call Transcript Highlights: Navigating Through ... (GuruFocus.com)
May-15-24 08:53PM	BIOR Stock Earnings: Biora Therapeutics Beats EPS for Q1 2024 (InvestorPlace)
04:05PM	Biora Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-07-24 08:00AM	Biora Therapeutics to Report First Quarter 2024 Financial Results and Provide Corporate Update (GlobeNewswire)
May-06-24 08:00AM	Biora Therapeutics to Present Clinical Data on Device Function of the NaviCap Oral Delivery Platform at Digestive Disease Week 2024 (GlobeNewswire)
Apr-30-24 08:00AM	Biora Therapeutics Announces Completion of Multiple-Ascending Dose (MAD) Cohorts for Clinical Trial of BT-600 (GlobeNewswire) +5.29%
Apr-08-24 08:00AM	Biora Therapeutics Announces New Patent Covering its BioJet Liquid Jet Delivery Technology (GlobeNewswire)
Apr-04-24 08:00AM	Biora Therapeutics Achieves Positive Interim Results for Clinical Trial of BT-600, Advancing NaviCap Platform Development (GlobeNewswire)
Apr-03-24 04:05PM	Biora Therapeutics Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (GlobeNewswire)
Apr-01-24 08:00AM	Biora Therapeutics Announces $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (GlobeNewswire) -33.15%
12:18PM	Loading…
Mar-27-24 12:18PM	Biora Therapeutics, Inc. (NASDAQ:BIOR) Q4 2023 Earnings Call Transcript (Insider Monkey) -12.03%
06:18AM	Q4 2023 Biora Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-26-24 08:53PM	BIOR Stock Earnings: Biora Therapeutics Misses EPS for Q4 2023 (InvestorPlace) +9.02%
04:05PM	Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results (GlobeNewswire)
Mar-18-24 08:00AM	Biora Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update (GlobeNewswire)
Mar-11-24 08:00AM	Biora Therapeutics Further Reduces Net Debt and Monetizes Legacy Asset (GlobeNewswire) +6.72%
Feb-26-24 08:00AM	Biora Therapeutics Announces Successful Completion of Single-Ascending Dose (SAD) Cohorts of Phase 1 Clinical Study of BT-600 (GlobeNewswire) +23.70%
Feb-08-24 08:00AM	Biora Therapeutics Announces Participation in Canaccord Genuity Inflammatory Bowel Disease Symposium (GlobeNewswire)
Jan-22-24 08:00AM	Biora Therapeutics Announces Participation in Fireside Chat Hosted by H.C. Wainwright & Co. (GlobeNewswire)
Jan-16-24 08:00AM	Biora Therapeutics Provides Outlook for 2024 (GlobeNewswire)
Jan-08-24 08:00AM	Biora Therapeutics Announces Initiation of Phase 1 Clinical Study of BT-600 (GlobeNewswire) -5.19%
Jan-02-24 08:00AM	Biora Therapeutics Progresses Research Collaboration for the BioJet Systemic Oral Delivery Platform (GlobeNewswire)
Dec-19-23 08:00AM	Biora Therapeutics Announces New Patent for its NaviCap Targeted Oral Delivery Platform (GlobeNewswire)
Dec-18-23 08:00AM	Biora Therapeutics Accelerates Debt Reduction and Raises Capital with Large Institutional Investors (GlobeNewswire) -12.50%
Dec-11-23 08:00AM	Biora Therapeutics Announces New Research Collaboration for the BioJet Systemic Oral Delivery Platform (GlobeNewswire) +22.22%
07:41AM	Loading…
Dec-01-23 07:41AM	Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace) +8.87%
Nov-30-23 04:48PM	Biora Therapeutics Announces FDA Clearance of IND Application for Drug/Device Combination BT-600 Targeting Treatment of Ulcerative Colitis (GlobeNewswire)
Nov-14-23 09:37AM	Biora Therapeutics, Inc. (NASDAQ:BIOR) Q3 2023 Earnings Call Transcript (Insider Monkey)
07:01AM	Q3 2023 Biora Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-13-23 04:05PM	Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-06-23 08:00AM	Biora Therapeutics to Report Third Quarter 2023 Financial Results and Provide Corporate Update (GlobeNewswire) -9.52%
Oct-30-23 04:05PM	Biora Therapeutics Submits Updated IND Application for BT-600 (GlobeNewswire)
Oct-23-23 05:30PM	Biora Therapeutics to Submit Updated IND Application for BT-600 (GlobeNewswire) -6.87% -13.93%
Oct-18-23 05:25AM	BIOR: Precision Release Surgical Strike on the GI Tract (Zacks) +16.67%
Oct-05-23 08:00AM	Biora Therapeutics Presents Data on the BioJet Systemic Oral Delivery Platform at the 59th Annual Meeting of the European Association for the Study of Diabetes (GlobeNewswire)
Sep-25-23 08:00AM	Biora Therapeutics Announces Submission of IND Application to the U.S. FDA for BT-600 Program (GlobeNewswire)
Sep-22-23 05:00AM	Hidden Gems: 3 Penny Stocks Flying Under the Radar. (InvestorPlace)
Sep-19-23 08:00AM	Biora Therapeutics Reduces Debt and Largest Shareholder Increases Equity Exposure (GlobeNewswire)
Sep-11-23 08:01AM	Biora Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Sep-05-23 08:00AM	Biora Therapeutics Progresses its BioJet Systemic Oral Delivery Platform (GlobeNewswire) +10.40%
Aug-14-23 04:01PM	Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results (GlobeNewswire) -8.38%
Aug-03-23 08:00AM	Biora Therapeutics Announces New Patents Covering its BioJet Systemic Oral Delivery Platform (GlobeNewswire)
Aug-02-23 08:00AM	Biora Therapeutics to Participate in Canaccord Genuity 43rd Annual Growth Conference (GlobeNewswire)
Jul-27-23 08:00AM	Biora Therapeutics Announces Clinical Device Performance Study Results for its NaviCap Targeted Oral Delivery Platform (GlobeNewswire)
Jul-17-23 06:00AM	Biora Therapeutics to Report Second Quarter 2023 Financial Results and Provide Corporate Update (GlobeNewswire)
Jul-05-23 08:00AM	Biora Therapeutics Continues to Monetize Legacy Diagnostics Assets (GlobeNewswire)
Jun-28-23 08:30AM	Biora Therapeutics Announces New Patents for its NaviCap Targeted Oral Delivery Platform (GlobeNewswire) +5.92%
Jun-26-23 06:00AM	Biora Therapeutics Presents Data on the BioJet Systemic Oral Delivery Platform at the American Diabetes Association 83rd Scientific Sessions (GlobeNewswire)
Jun-14-23 04:05PM	Biora Therapeutics Announces Closing of $8 Million Registered Direct Offering of Common Stock and Warrants Priced At-the-Market Under Nasdaq Rules (GlobeNewswire) -7.76% -8.84%
Jun-13-23 08:00AM	Biora Therapeutics Announces $8 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (GlobeNewswire) -18.30%
Jun-08-23 09:00AM	Biora Therapeutics to Present Preclinical Data on the BioJet Systemic Oral Delivery Platform at the 59th Annual Meeting of the European Association for the Study of Diabetes (GlobeNewswire)
May-24-23 08:00AM	3 Biotech Stocks That Could Turn $1,000 into $10,000 by 2024 (InvestorPlace) +18.39%
May-17-23 01:53PM	Biora Therapeutics, Inc. (NASDAQ:BIOR) Q1 2023 Earnings Call Transcript (Insider Monkey)
May-16-23 05:44AM	Q1 2023 Biora Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
May-15-23 04:05PM	Biora Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results (GlobeNewswire) -10.90%
May-08-23 09:00AM	Biora Therapeutics to Report First Quarter 2023 Financial Results and Provide Corporate Update (GlobeNewswire)
May-01-23 09:00AM	Biora Therapeutics Appoints Dr. Ariella Kelman as Chief Medical Officer (GlobeNewswire)
Apr-20-23 04:46PM	Biora Therapeutics to Participate in Crohns & Colitis Foundations IBD Innovate Conference (GlobeNewswire)
Apr-05-23 07:46PM	Biora Therapeutics, Inc. (NASDAQ:BIOR) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-30-23 04:01PM	Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2022 Financial Results (GlobeNewswire)
Mar-23-23 09:00AM	Biora Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update (GlobeNewswire)
Feb-23-23 09:00AM	Biora Therapeutics Announces Bioavailability Results for Oral Delivery of GLP-1 Receptor Agonist (GlobeNewswire)
Feb-16-23 09:40AM	Is Butterfly Network (BFLY) Outperforming Other Medical Stocks This Year? (Zacks) -5.20%
09:00AM	Biora Therapeutics Announces Improved Bioavailability Results for its Systemic Delivery Platform (GlobeNewswire)
Feb-02-23 09:55AM	Biora Therapeutics, Inc. (BIOR) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? (Zacks)
Jan-19-23 04:05PM	Biora Therapeutics Presents Data from Device Performance Study with Repeat Doses in Both Fasted and Fed States at Crohns & Colitis Congress (GlobeNewswire) -10.52%
Jan-09-23 09:00AM	Biora Therapeutics Receives Pre-IND Feedback from FDA and Provides Update on Key Programs for 2023 (GlobeNewswire)
Dec-30-22 09:00AM	Biora Therapeutics Announces Reverse Stock Split (GlobeNewswire) -12.84%
Dec-08-22 04:05PM	Biora Therapeutics Announces Two Poster Presentations at the Crohns & Colitis Congress (GlobeNewswire) -8.77%
Nov-29-22 09:00AM	Biora Therapeutics Licenses Preeclampsia Rule-Out Test for Commercial Development (GlobeNewswire) +10.57%
Nov-17-22 05:37AM	Biora Therapeutics Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag (Simply Wall St.) -8.26%
Nov-14-22 05:35PM	Biora Therapeutics, Inc. (BIOR) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:01PM	Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Nov-07-22 04:15PM	Biora Therapeutics to Report Third Quarter 2022 Financial Results and Provide Corporate Update (GlobeNewswire) -12.05% -6.81%
08:06AM	Biora Therapeutics Announces $9.75 Million Direct Offering (GlobeNewswire)
Oct-27-22 09:00AM	Biora Therapeutics Announces Sale of Cell-Free DNA Patent Rights (GlobeNewswire)
Oct-25-22 09:00AM	Biora Therapeutics Shares Data from Device Performance Study in Ulcerative Colitis Patients (GlobeNewswire) +6.03%
Oct-24-22 09:00AM	Biora Therapeutics Shares Five Posters Presented at American College of Gastroenterology Annual Scientific Meeting 2022 (GlobeNewswire)
Oct-19-22 09:00AM	Biora Therapeutics Shares Preclinical Data on Oral Delivery of Biologics at the 2022 Parenteral Drug Association Universe of Pre-Filled Syringes and Injection Devices Conference (GlobeNewswire)
Oct-10-22 09:00AM	Biora Therapeutics to Participate in 12th Annual Partnership Opportunities in Drug Delivery Conference (GlobeNewswire) -6.96%
Sep-13-22 09:00AM	Biora Therapeutics Announces Issuance of Key Patent for Oral Delivery of GLP-1 Receptor Agonists (GlobeNewswire)
Sep-07-22 09:00AM	Biora Therapeutics Appoints Dr. Bruce Sands as Chair of its Clinical Advisory Board (GlobeNewswire)
Sep-06-22 06:30AM	Biora Therapeutics to Participate in Upcoming H.C. Wainwright Investment Conference (GlobeNewswire)
Aug-15-22 04:05PM	Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results (GlobeNewswire) -6.00%
Aug-12-22 09:30AM	10 Best One Dollar Stocks To Buy Now (Insider Monkey) +7.53%
Aug-10-22 09:00AM	Biora Therapeutics Announces Successful Completion of Device Performance Study in Ulcerative Colitis Patients for its Targeted Therapeutics Platform (GlobeNewswire) +31.17%
Aug-08-22 09:00AM	Biora Therapeutics to Report Second Quarter 2022 Financial Results and Provide Corporate Update (GlobeNewswire)
Aug-03-22 09:00AM	Biora Therapeutics Announces Five Abstracts Accepted at American College of Gastroenterology Annual Scientific Meeting 2022 (GlobeNewswire)
Jul-26-22 09:00AM	Biora Therapeutics to Participate in Upcoming BTIG Investment Conference (GlobeNewswire)
Jul-14-22 09:00AM	Biora Therapeutics Shares Preclinical Data on Oral Delivery of Biologics at Controlled Release Society 2022 (GlobeNewswire)
Jul-07-22 09:00AM	Biora Therapeutics Announces Successful Completion of Second Device Performance Study in Human Subjects for its Targeted Therapeutics Platform (GlobeNewswire) +9.35%
Jun-22-22 09:00AM	Biora Therapeutics Announces Presentation at the 2022 Parenteral Drug Association Universe of Pre-Filled Syringes and Injection Devices Conference (GlobeNewswire)
May-31-22 09:00AM	Biora Therapeutics Shares Presentation of Patient Data Establishing Correlation Between Drug Levels in Colon and Patient Outcomes in Ulcerative Colitis (GlobeNewswire)
May-25-22 09:00AM	Biora Therapeutics Shares Data Presented at Digestive Disease Week 2022 (GlobeNewswire)
May-19-22 09:00AM	Biora Therapeutics Announces New Patents for Targeted Therapeutics Platform (GlobeNewswire)

Biora Therapeutics, Inc. engages in the provision of molecular and specialized diagnostic tests to clinicians. Its products include the Preparent Carrier Test, Innatal Prenatal Screen, Riscover Hereditary Cancer Test, and Resura Prenatal Test. The company was founded by Paul W. Hawran and Harry Stylli in 2010 and is headquartered in San Diego, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BIOR

Biora Therapeutics Inc

Upgrade your FINVIZ experience